Clinical research of diagnosis for lymph node metastases of gastrointestinal cancer by using 5-aminolevulinic acid

Clinical research of diagnosis for lymph node metastases of gastrointestinal cancer by using 5-aminolevulinic acid - Clinical research of diagnosis for lymph node metastases by using 5-ALA

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005080

Enrollment

100

Registered

2011-02-14

Start date

2009-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer, gastric cancer, esophageal cancer

Interventions

Oral administration of 5-aminolevulinic acid before surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: gastrointeistinal cancer diagnosed before surgery

Exclusion criteria

Exclusion criteria: Porphyria Recipient of drugs inducing photosensitivity Pregnant women and women suspected of being pregnant Patients who did not agree with this study Patients whom doctors decided as not a candidate.

Design outcomes

Primary

Measure	Time frame
evaluation of the diagnosis rate of the lymph node metastasis	—

Countries

Japan

Contacts

Public ContactYoshinori Harada

Kyoto prefectual University of Medicine Department of Pathology and Cell Regulation

yoharada@koto.kpu-m.ac.jp075-251-5322

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026